SEAN HANNITY (HOST): Now we turn to the latest medical news. In the battle against coronavirus and this pandemic, Dr. Oz, he warned this morning on Fox & Friends that, quote, “New York City is a war zone.” He added that the rest of America better take precautions but hope may be on the horizon. We will soon know because the FDA gave emergency authorization. Now, doctors can prescribe hydroxychloroquine for the coronavirus along with azithromycin.
Here now with more is Dr. Oz. Dr. Oz, I wanted to just say something that I know because you have literally been working around the clock talking to every doctor, in every country, putting them on your show, patients that have used hydroxychloroquine, and azithromycin. How hopeful are you? I know it's anecdotal, but everything seems to point towards this works.
DR. MEHMET OZ: Well, we need the clinical trials as you emphasized. But I spoke to Didier Raoult, the French physician, the iconic infectious disease doctor who put this on the map for me anyway. He got the idea, in fairness, from the Chinese who have made a part of their routine strategies. It's actually in their guidelines for managing COVID-19. But what he did over the weekend was shared with me and subsequently published, an 80-patient summary; 80 people who got both those drugs, the antimalarial, and the Z-pak basically.
And there's three basic things you can look for. Was it safe? He did not have complications related to the drugs. Did it reduce infectivity? It did. Within a week, almost all the patients were no longer infectious, which is really important because that means you can transfer them out of the infected areas into the general ward, which he did in his hospital in Marseilles, and that's huge for the patient flow in a hospital. You can accommodate a lot more people obviously. You don't need all the protective gear, et cetera, and your family can visit you. And finally, did it work? Well, he had 80 patients, as I mentioned, one died, one still in the ICU, because he's still publishing as he collects data. That result is significantly better, I should say -- meaningfully better than what you would have expected from this outcome.
So, without the randomized data, you just can't tell, because patient [UNINTELLIGIBLE] buys it, but I think the FDA did the right thing when they decided to allow physicians in this country to use this medication while we're trying to figure out what these clinical trials will show us, because it will take some time. Why put patients through turmoil. And it seems to be safe, if it's prescribed by a doctor and used appropriately.
HANNITY: And that's 79 out of 80. Now, we have an 1,100-patient clinical study ongoing now in New York as we speak. We might be getting results fairly quickly, I hope, or at least preliminary numbers. The main question, I think this is key -- and I've asked you this question. If it was a family member of yours or somebody you love and care about or yourself, everything I've read -- and I'm not a doctor, I'm not going to play one on TV, but I would absolutely immediately use it based on all that I've read, and you have shared a lot of data with me yourself and I appreciate it.
OZ: I would use the medication. Most of the physicians that I've spoken to, and it's bio sampling, which say the same, and their patients are writing to me all the time. Again, the success stories write, the ones that don't wouldn't. It's not a panacea. It's not going to work for everybody, and we don't know if it's that much more effective than standard care, but the people who use it sometimes say it changed things pretty dramatically.